Conjugates Comprising An Anti-EGFR1 Antibody
AssigneeTenboron Oy
InventorsAnne Leppanen, Filip S. Ekholm, Jari Helin, Hanna Salo, Anne Kanerva
Life of this patent
Estimating the term…
Loading patent…
AssigneeTenboron Oy
InventorsAnne Leppanen, Filip S. Ekholm, Jari Helin, Hanna Salo, Anne Kanerva
Estimating the term…
The present invention relates to a conjugate comprising an anti-EGFR1 antibody or an EGFR binding fragment thereof and at least one dextran derivative, wherein the dextran derivative comprises at least one D-glucopyranosyl unit, wherein at least one carbon selected from carbon 2, 3 or 4 of the at least one D-glucopyranosyl unit is substituted by a substituent of the formula —O—(CH2)”—S—Bi2Hii2− wherein n is in the range of 3 to 10; and the dextran derivative is bound to the anti-EGFR antibody or an EGFR1 binding fragment thereof via a bond formed by a reaction between at least one aldehyde group formed by oxidative cleavage of a D-glucopyranosyl unit of the dextran derivative and an amino group of the anti-EGFR1 antibody or an EGFR1 binding fragment thereof.
A conjugate comprising an anti-EGFRl antibody or an EGFRl binding fragment thereof and at least one dextran derivative, wherein
A prokaryotic host cell comprising one or more polynucleotides encoding
A polynucleotide encoding
A polynucleotide encoding
A polynucleotide encoding
A polynucleotide encoding
The polynucleotide according to 57-61, wherein the signal peptide preceding the light chain variable region is other than the signal peptide preceding the heavy chain variable region.
Dependencies are inferred from the claim text.